Cornerstone Planning Group LLC Pacira Bio Sciences, Inc. Transaction History
Cornerstone Planning Group LLC
- $624 Billion
- Q3 2025
A detailed history of Cornerstone Planning Group LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 61 shares of PCRX stock, worth $1,471. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61
Previous 18
238.89%
Holding current value
$1,471
Previous $406,000
2853.2%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
50.4MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$193 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$125 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$54.4 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$52.2 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.14MShares$51.6 Million0.08% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.11B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...